Alice Yam

1.8k total citations
20 papers, 1.2k citations indexed

About

Alice Yam is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Alice Yam has authored 20 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Oncology. Recurrent topics in Alice Yam's work include Monoclonal and Polyclonal Antibodies Research (6 papers), Prion Diseases and Protein Misfolding (4 papers) and Heat shock proteins research (4 papers). Alice Yam is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (6 papers), Prion Diseases and Protein Misfolding (4 papers) and Heat shock proteins research (4 papers). Alice Yam collaborates with scholars based in United States, Switzerland and Sweden. Alice Yam's co-authors include Judith Frydman, Véronique Albanèse, Alma L. Burlingame, Yu Xia, Mark Gerstein, Joshua M. Baughman, Charles Parnot, Trevor J. Hallam, Aaron K. Sato and Christopher D. Thanos and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Alice Yam

18 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alice Yam United States 12 990 271 203 165 134 20 1.2k
Weijia Ou United States 14 940 0.9× 166 0.6× 102 0.5× 401 2.4× 105 0.8× 15 1.3k
Eugenia Polverini Italy 21 822 0.8× 61 0.2× 123 0.6× 116 0.7× 48 0.4× 48 1.3k
Yu Kitago Japan 14 447 0.5× 71 0.3× 56 0.3× 97 0.6× 148 1.1× 21 697
Elizabeth A. Ottinger United States 20 1.1k 1.2× 96 0.4× 163 0.8× 137 0.8× 152 1.1× 35 1.6k
Markus Streiff Switzerland 21 1.0k 1.1× 96 0.4× 151 0.7× 116 0.7× 58 0.4× 47 1.4k
Nicolas Floquet France 23 890 0.9× 87 0.3× 89 0.4× 87 0.5× 79 0.6× 45 1.4k
Bertil Macao Sweden 17 942 1.0× 69 0.3× 84 0.4× 96 0.6× 411 3.1× 26 1.2k
Terry T. Takahashi United States 18 1.1k 1.1× 360 1.3× 147 0.7× 112 0.7× 33 0.2× 31 1.4k
Michael P. Schlunegger Switzerland 7 1.2k 1.2× 71 0.3× 94 0.5× 127 0.8× 109 0.8× 9 1.4k
Nobumasa Hino Japan 17 1.0k 1.0× 123 0.5× 64 0.3× 71 0.4× 51 0.4× 32 1.2k

Countries citing papers authored by Alice Yam

Since Specialization
Citations

This map shows the geographic impact of Alice Yam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alice Yam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alice Yam more than expected).

Fields of papers citing papers by Alice Yam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alice Yam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alice Yam. The network helps show where Alice Yam may publish in the future.

Co-authorship network of co-authors of Alice Yam

This figure shows the co-authorship network connecting the top 25 collaborators of Alice Yam. A scholar is included among the top collaborators of Alice Yam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alice Yam. Alice Yam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yuan, Robert, Andrew McGeehan, Sihong Zhou, et al.. (2025). The Anti-FRα Antibody–Drug Conjugate Luveltamab Tazevibulin Demonstrates Efficacy in Non–Small Cell Lung Cancer Preclinical Models and Induces Immunogenic Cell Death. Molecular Cancer Therapeutics. 24(9). 1428–1441. 1 indexed citations
2.
3.
Li, Xiaofan, Cristina L. Abrahams, Abigail Yu, et al.. (2023). Targeting CD74 in B-cell non-Hodgkin lymphoma with the antibody-drug conjugate STRO-001. Oncotarget. 14(1). 1–13. 5 indexed citations
4.
Yam, Alice, Helena Kiefel, Andrew McGeehan, et al.. (2023). Abstract 4894: The anti-ROR1 ADC STRO-003 demonstrates immune-modulating properties that may enhance checkpoint blockade. Cancer Research. 83(7_Supplement). 4894–4894. 1 indexed citations
5.
Hornemann, Simone, Petra Schwarz, Elisabeth J. Rushing, et al.. (2019). Enhanced detection of prion infectivity from blood by preanalytical enrichment with peptoid-conjugated beads. PLoS ONE. 14(9). e0216013–e0216013. 4 indexed citations
6.
Abrahams, Cristina L., Xiaofan Li, Millicent Embry, et al.. (2018). Targeting CD74 in multiple myeloma with the novel, site-specific antibody-drug conjugate STRO-001. Oncotarget. 9(102). 37700–37714. 45 indexed citations
7.
8.
Embry, Millicent, Xiaofan Li, Abigail Yu, et al.. (2017). CD74 Is Expressed in Relapsed and Refractory Multiple Myeloma and Can be Targeted with a Novel Anti-CD74 Antibody Drug Conjugate, SΤRO-001. Blood. 130. 4420–4420. 1 indexed citations
9.
Molina, A., Amy S. Yu, Cristina L. Abrahams, et al.. (2017). STRO‐001, A NOVEL ANTI‐CD74 ANTIBODY DRUG CONJUGATE (ADC) FOR TREATMENT OF B‐CELL NON‐HODGKIN'S LYMPHOMAS (NHL). Hematological Oncology. 35(S2). 255–256. 1 indexed citations
10.
Zimmerman, Erik S., Tyler H. Heibeck, Avinash Gill, et al.. (2014). Production of Site-Specific Antibody–Drug Conjugates Using Optimized Non-Natural Amino Acids in a Cell-Free Expression System. Bioconjugate Chemistry. 25(2). 351–361. 277 indexed citations
11.
Groff, Dan, Juan Zhang, Junhao Yang, et al.. (2014). Engineering toward a bacterial “endoplasmic reticulum” for the rapid expression of immunoglobulin proteins. mAbs. 6(3). 671–678. 51 indexed citations
12.
Margalith, Ilan, Boris Ballmer, Petra Schwarz, et al.. (2012). Polythiophenes Inhibit Prion Propagation by Stabilizing Prion Protein (PrP) Aggregates. Journal of Biological Chemistry. 287(23). 18872–18887. 48 indexed citations
13.
Yam, Alice, Xuemei Wang, Michael D. Connolly, et al.. (2011). A Universal Method for Detection of Amyloidogenic Misfolded Proteins. Biochemistry. 50(20). 4322–4329. 31 indexed citations
14.
Yam, Alice, et al.. (2010). The Octarepeat Region of the Prion Protein Is Conformationally Altered in PrPSc. PLoS ONE. 5(2). e9316–e9316. 18 indexed citations
15.
Yam, Alice, Xuemei Wang, Cleo M. Salisbury, et al.. (2010). Aβ40 Oligomers Identified as a Potential Biomarker for the Diagnosis of Alzheimer's Disease. PLoS ONE. 5(12). e15725–e15725. 83 indexed citations
16.
Yam, Alice, et al.. (2008). Defining the TRiC/CCT interactome links chaperonin function to stabilization of newly made proteins with complex topologies. Nature Structural & Molecular Biology. 15(12). 1255–1262. 315 indexed citations
17.
Lau, Anthony L., Alice Yam, Robert J. Goodson, et al.. (2007). Characterization of prion protein (PrP)-derived peptides that discriminate full-length PrP Sc from PrP C. Proceedings of the National Academy of Sciences. 104(28). 11551–11556. 48 indexed citations
18.
Albanèse, Véronique, Alice Yam, Joshua M. Baughman, Charles Parnot, & Judith Frydman. (2006). Systems Analyses Reveal Two Chaperone Networks with Distinct Functions in Eukaryotic Cells. Cell. 124(1). 75–88. 209 indexed citations
19.
Etchells, Stephanie A., Anne S. Meyer, Alice Yam, et al.. (2005). The Cotranslational Contacts between Ribosome-bound Nascent Polypeptides and the Subunits of the Hetero-oligomeric Chaperonin TRiC Probed by Photocross-linking. Journal of Biological Chemistry. 280(30). 28118–28126. 33 indexed citations
20.
Yam, Alice, et al.. (2005). Hsp110 Cooperates with Different Cytosolic HSP70 Systems in a Pathway for de Novo Folding. Journal of Biological Chemistry. 280(50). 41252–41261. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Weijia Ou Breakdown of academic impact, for papers by Eugenia Polverini Breakdown of academic impact, for papers by Yu Kitago Breakdown of academic impact, for papers by Elizabeth A. Ottinger Breakdown of academic impact, for papers by Markus Streiff Breakdown of academic impact, for papers by Nicolas Floquet Breakdown of academic impact, for papers by Bertil Macao Breakdown of academic impact, for papers by Terry T. Takahashi Breakdown of academic impact, for papers by Michael P. Schlunegger Breakdown of academic impact, for papers by Nobumasa Hino
Rankless by CCL
2026